N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobody
2023 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobody
Zibat, A.; Zhang, X.; Dickmanns, A.; Stegmann, K. M.; Dobbelstein, A. W.; Alachram, H. & Soliwoda, R. et al. (2023)
iScience, 26(10) art. 107786. DOI: https://doi.org/10.1016/j.isci.2023.107786
Documents & Media
Details
- Authors
- Zibat, Arne; Zhang, Xiaoxiao; Dickmanns, Antje; Stegmann, Kim M.; Dobbelstein, Adrian W.; Alachram, Halima; Soliwoda, Rebecca; Salinas, Gabriela; Groß, Uwe; Görlich, Dirk; Dobbelstein, Matthias
- Issue Date
- 2023
- Journal
- iScience
- Project
- EXC 2067: Multiscale Bioimaging
- Working Group
- RG Dobbelstein
RG Wollnik - ISSN
- 2589-0042
- Language
- English
- Sponsor
- Open-Access-Publikationsfonds 2023
